Nuvaira Stock
Develops devices for treating lung diseases
Sign up today and learn more about Nuvaira Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nuvaira Stock
Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.
Funding History
| September 2010 | $3.0M |
|---|---|
| May 2011 | $5.0M |
| September 2012 | $10.6M |
| February 2013 | $10.0M |
| April 2014 | $40.0M |
| February 2019 | $79.0M |
Management
President and CEO
Dennis Wahr
Founder & CTO
Martin L. Mayse
Director of Regulatory Affairs
Mahtab Fatemi
Vice President Clinical Affairs
Jim Pavliska
CFO
Kari Kubesh
Senior Vice President Operations
Steve Mertens
Board of Directors, President and CEO
Dennis W. Wahr
Vice President International Development
Scott Grant
Press
biospace - Aug, 12 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestonemassdevice - Jun, 8 2020
Nuvaira gains FDA breakthrough nod for lung denervation systembit - May, 29 2020
Nuvaira announces Griffin as new CFOprnewswire - Aug, 20 2019
Nuvaira Announces Peer-Reviewed Publications of Targeted Lung Denervation Mechanisms of Action and Clinical Outcomesprnewswire - Jun, 11 2019
First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trialpehub - Feb, 15 2019
Nuvaira nets $79 mln in USVP-led roundfiercebiotech - Feb, 12 2019
Nuvaira raises $79M for lung nerve ablation procedure for COPD and asthmacbj - Nov, 3 2016
Holaira Hosts Educational Symposium on Targeted Lung Denervation (TLD) in Obstructive Lung Disease at ERSpehub - Apr, 15 2016
Foundry Innovation & Research 1 raises $7.5 mlngeekwire - Sep, 29 2015
Innovative Pulmonary changes name, raises $10M and moves to Minnesotabusinesswire - Sep, 29 2015
LifeScience Alley Names New Board of Directorsmassdevice - Sep, 29 2015
Kips Bay Medical pulls the plugmassdevice - Sep, 29 2015
Sanovas wins FDA 510(k) clearance for PulmoViamassdevice - Sep, 29 2015
Medtech investment hits 6-year high in Minnesotamassdevice - Sep, 29 2015
Medtech funding soars in Minnesota in Q2massdevice - Sep, 29 2015
Verisante, Astoria join forces for upper GI cancer detectionmassdevice - Sep, 29 2015
Holaira lands $42M for lung denervation trialyourstory - Apr, 29 2015
Midwest region of the US emerges as healthcare startup hubfinsmes - Apr, 3 2014
FinSMEs | Holaira Raises $42M in Series D FundingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
